Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids

Bioinorganic Chemistry
K Timmers, R Sternglanz

Abstract

The ionization constants and some divalent cation dissociation constants of nalidixic and oxolinic acids, both specific inhibitors of bacterial DNA replication, have been determined. The carboxylic pKa' values are 6.1 and 6.9 at 25 degrees for nalidixic and oxolinic acids, respectively. These values indicate that intramolecular hydrogen-bonding stabilizes the un-ionized form of these compounds in aqueous solution. Both compounds bind divalent cations; the divalent cation dissociation constants for oxolinic acid are somewhat smaller that those for nalidixic acid. We suggest that both compounds may act by forming a complex in situ with a divalent cation in a metalloprotein involved in DNA replication. The evidence that both drugs inhibit at the same target site is briefly reviewed.

References

Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·M GellertH A Nash
Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A SuginoN R Cozzarelli
Nov 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·M GellertJ I Tomizawa
Mar 1, 1976·European Journal of Biochemistry·W L Staudenbauer
Aug 6, 1973·Biochemical and Biophysical Research Communications·P ValenzuelaW J Rutter
Dec 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszL A Loeb
Oct 1, 1973·Antimicrobial Agents and Chemotherapy·G J BourguignonR Sternglanz
Jan 28, 1972·Journal of Molecular Biology·H SchallerF Bonhoeffer
Feb 15, 1972·European Journal of Biochemistry·A M PedriniA Falaschi
Jul 2, 1971·Biochemical and Biophysical Research Communications·J P SlaterL A Loeb
Oct 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·M C ScruttonD A Goldthwait
Apr 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·L M Chang, F J Bollum
May 1, 1968·Journal of Bacteriology·R S PianottiB S Schwartz
May 1, 1964·Toxicology and Applied Pharmacology·E W MCCHESNEYD ROSI
Apr 1, 1962·The Journal of General Psychology·H LIFTON, A E GOSS

❮ Previous
Next ❯

Citations

Jan 1, 1988·Molecular & General Genetics : MGG·H YoshidaS Nakamura
Oct 19, 1990·Pharmaceutisch Weekblad. Scientific Edition·J R BrouwersJ H Proost
Oct 1, 1991·Journal of Photochemistry and Photobiology. B, Biology·F VargasR Machado
Sep 3, 2002·European Journal of Medicinal Chemistry·Hyoung-Ryun ParkKi-Min Bark
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·L L Shen, A G Pernet
Mar 1, 1991·British Journal of Clinical Pharmacology·N R Campbell, B B Hasinoff
Mar 1, 1991·British Journal of Clinical Pharmacology·M KaraN R Campbell
Mar 1, 1992·British Journal of Clinical Pharmacology·P J Neuvonen, K T Kivistö
Jan 1, 1984·Photochemistry and Photobiology·D E MooreH Yip
May 1, 1989·Antimicrobial Agents and Chemotherapy·T H GraselaA W Kinkel
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·J ShimadaS Yamamoto
Oct 1, 1993·Antimicrobial Agents and Chemotherapy·M LazzaroniG Bianchi Porro
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·S LecomteN J Moreau
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tetsumi Yamakawa, Setsuko Nishimura
Jun 27, 2009·Bioinorganic Chemistry and Applications·Egla Yareth Bivián-CastroGuillermo Mendoza-Díaz
Aug 19, 2005·Photochemistry and Photobiology·Paulina PavezMaria Victoria Encinas
May 24, 2007·Drug Development and Industrial Pharmacy·Subrata MallickArindam Saha
Jul 9, 2008·Drug Development and Industrial Pharmacy·Subrata MallickGaurisankar Ghoshal
Apr 4, 1997·The Journal of Biological Chemistry·D P WoolridgeA A Neyfakh
Jan 9, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Angela F Danil de NamorBrendan Howlin
Aug 1, 2018·The Journal of Pharmacy and Pharmacology·Chara LitouJennifer B Dressman
Sep 29, 2011·Drugs·Ryuichi Ogawa, Hirotoshi Echizen
Jun 1, 1991·DICP : the Annals of Pharmacotherapy·A D Van SlootenH R Goldstein
Apr 1, 1995·Journal of Chemotherapy·M H TeixeiraF Teixeira
Dec 8, 2017·Environmental Science & Technology·Wei ChengKhalil Hanna
Sep 21, 2001·Environmental Science & Technology·J Tolls

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.